GL1X · GenesisL1 explorer

Research workbench

Structure of the EC2 domain of CD9 in complex with nanobody 4C8

Analyse Structure of the EC2 domain of CD9 in complex with nanobody 4C8 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6Z20
Type
protein
Length
398 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CD9 antigen; Nanobody 4C8
UniProt
P21926
Ligands
CL

Structure

x-ray diffraction · 3 distinct chains · 40% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACD9 antigenprotein7963% helix, 5% strandP21926
B, DNanobody 4C8protein1208% helix, 51% strand—
CCD9 antigenprotein7965% helix, 3% strandP21926

Ligands and binding sites

  • CL · Chloride ion · ion · chains D
  • GOL · Glycerol · additive · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

3 interfaces between chains.

  • A–C · 713 Ų buried · 4 hydrogen bonds · protein-protein
  • A–B · 675 Ų buried · 15 hydrogen bonds · protein-protein
  • C–D · 605 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 6Z20 · Structure of the EC2 domain of CD9 in complex with nanobody 4C8 · the same entry in another collection · chain A against A, TM-score 1.00
  • P21926 · AlphaFold monomer V2.0 prediction for CD9 antigen (P21926) · a predicted model of the same protein · chain A against A, TM-score 0.71

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.